Page last updated: 2024-10-22

amiodarone and Bronchial Hyperreactivity

amiodarone has been researched along with Bronchial Hyperreactivity in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Voshaar, T1

Other Studies

1 other study available for amiodarone and Bronchial Hyperreactivity

ArticleYear
[Comments on the contribution by B.-D. Gonska (drug therapy). Amiodarone].
    Der Internist, 1994, Volume: 35, Issue:2

    Topics: Amiodarone; Bronchial Hyperreactivity; Humans; Lung Diseases, Obstructive; Pulmonary Fibrosis; Risk

1994